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Summary Fifty retinoblastoma families have been studied. In 41 it has been possible to determine the
esterase-D phenotypes in all family members. Seven families were informative for the enzyme polymorphism
and in all cases cosegregation of the retinoblastoma gene and esterase-D alleles was demonstrated, giving a
lod score of 2.61. When combined with other published reports the cumulative lod score is 13.69 with no
recombination in 45 meioses. In 10-15% of retinoblastoma families therefore, it is possible to offer prenatal
diagnosis using the ESD protein polymorphism. The application of this test to the retinoblastoma population
in the UK is limited by the low frequency of the rarer allele (0.116) and, as a result of genetic counselling,
the smaller families generally associated with retinoblastoma.
Retinoblastoma (Rb) is an intraocular tumour of children
which occurs in both sporadic and hereditary forms
(Sparkes, 1985; Cowell, 1985). The inheritance follows an
autosomal dominant pattern with greater than 90%
penetrance. Approximately 1:20 Rb patients carries a
constitutional deletion on the long arm of chromosome 13
(Cowell et al., 1986a). The extent of the deletion varies from
patient to patient but in all cases part of chromosome band
13ql4 is missing. It was suggested by several authors that the
frequently deleted region was the proximal part of 13ql4
(Yunis & Ramsay 1978; Ward et al., 1984, Sparkes et al.,
1984) and in some cases the deletion is confined to that
region (Yunis & Ramsay, 1978). Other reports suggest a
more distal location of the critical region in 13q14 (Cowell et
al., 1986b, c). These observations suggest that, located in
region 13ql4, there is genetic information important in
determining predisposition to tumour formation.
Analysis of chromosome deletions from Rb patients has
also allowed Sparkes et al. (1980) to localise the esterase-D
gene (ESD) in band 13ql4, although sufficiently distant from
the Rb predisposition locus to allow separation by
chromosome translocation breakpoints (Sparkes et al., 1984;
Cowell et al., 1986c). The close physical proximity of the
ESD and Rb loci raised the possibility that the naturally
occurring electrophoretic variants of the ESD protein
described by Hopkinson et al. (1973) could be used to track
the inheritance of the predisposition through families (see
Cowell, 1985 for discussion) and permit antenatal diagnosis.
Sparkes et al. (1983) were able to show close linkage between
the two loci in an analysis of three families thus locating the
hereditary non-deletion form of the tumour to the same
region of chromosome 13. The relatively rare occurrence of
the familial form of Rb together with the low frequency of
heterozygotes at the ESD locus have made it difficult to
assess the exact recombination distance between the two loci.
In this report we present data from 50 Rb families from the
UK. By combining these data with other reports. Our aim
was to obtain a more accurate estimate of the linkage
between ESD and Rb.
Materials and methods
Sample processing
Blood samples were collected into tubes containing heparin
or EDTA as an anticoagulant and transported to the
Correspondence: J.K. Cowell.
Received 1 November 1986; and in revised form, 20 January 1987.
laboratory at ambient temperature. Aliquots were washed in
isotonic saline and the packed red cells lysed by resuspending
with 50% of the original volume of water and freezing at
-700C.
ESD phenotyping
Phenotypes were determined by electrophoresis through 11%
starch gels essentially as described previously (Cowell et al.,
1986d). Gels were run in 1% of 150mM citric acid, 250mM
sodium phosphate solution at pH 5.9 (bridge buffer). Ten pl
of the red cell lysate was loaded on Whatman 3M paper at
the cathode end of the gel which was run at 4°C and
4Vcm-1 for 17h. Gels were then sliced lengthwise and both
halves developed by covering the cut surface with 3M paper
soaked in 4-methylumbelliferyl acetate. After 5min the
fluorescent bands characteristic for each phenotype were
viewed using long wavelength UV light.
Results
The ophthalmology clinics at Moorfields Eye Hospital and
St. Bartholomew's Hospital in London are first and second
referral centres for retinoblastoma patients. As such the
majority of bilateral and familial cases from throughout the
UK are seen at those clinics. Other familial cases are referred
from abroad and two such cases are included in this study;
one from Pakistan and one from Spain. All sibs of proven
familial cases and bilateral cases are screened every three
months by ophthalmoscopy under general anaesthetic in the
first year, every four months in the second year and every six
months thereafter up to the age of five. The vast majority of
familial cases are identified during the first two years (Jay &
Hungerford, in preparation).
In all cases family histories were compiled for an ongoing
epidemiological study of Rb in the UK (Jay & Draper, in
preparation). A particularly mild form of retinoblastoma can
exist characterised by spontaneous regression of the tumour
or in the form of a retinal scar, termed retinoma (Gallie et
al., 1982). Wherever possible, therefore, the retinas of all
apparently unaffected family members were examined. The
presence of this phenotype was taken to indicate the
presence of the Rb gene. All tumours from enucleated eyes
were confirmed histologically as Rb.
Blood samples from all family members were collected
either at the clinics in London, through family visits, or via
local practitioners who sent patient's samples to the
laboratory by first class mail. In our series there were several
families in which more than one affected sib was born to
F
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unaffected parents but only families in which there were
affected members in at least two generations were included
in this survey.
ESD analysis
Phenotypic expression of the two common electrophoretic
variants has been analysed in 50 families. In 9 of these
families the analysis is incomplete although in all cases the
phenotypes of the affected transmitting members have been
determined. In the remaining 41 families the phenotypes of
all family members have been determined. Previous analysis
of ESD levels in these families (Cowell et al., 1986a) showed
them all to be within the normal range, thus excluding the
possibility of a detectable chromosome deletion. Of the 50
families analysed, 43 were uninformative: in 34 families all
individuals had the 1-1 phenotype and in 8 the affected
transmitting parent was 1-1 and the unaffected parent was
heterozygous. In one family both parents were heterozygotes.
Seven families were informative for the polymorphism
(Figure 1), and in all cases there was cosegregation of the Rb
and the particular ESD allele. In family seven (Figure 1),
phase has been established through the daughter in the first
marriage. The father and his second wife are currently being
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Figure 1 Segregation of the esterase-D electrophoretic variants
in seven retinoblastoma families informative for the
polymorphism. In each case the first born in the family is shown
on the left.. C - Unilateral; 0 - Bilateral.
In 6 of the families with an unaffected heterozygous
parent the affected children are heterozygotes including one
set of twins. These patients will be potentially informative
for the ESD polymorphism in the future.
Antenatal diagnosis of Rb using the ESD protein
polymorphism, depends on the ability to demonstrate
enzyme activity in chorionic villus and cord blood samples.
ESD analysis of cord blood samples derived from four
patients showing no ocular abnormalities has shown that
there is no quantitative or qualitative difference in enzyme
activity when compared with adult blood samples. We have
also been able to demonstrate that ESD phenotypes can be
determined from lysates prepared directly from two
chorionic villus samples and in cells from three different
short term villus cultures.
Linkage analysis
Pedigree analysis was performed using the LIPED
programme. The data for each informative family is
recorded in Table I. The cumulative lod score was highest at
0=0 with a value of 2.61. In this analysis the penetrance was
given as 90%, a figure which seems low from our experience
in the UK (unpublished observations). Assessing the
penetrance at 95% however made no difference to the
results. The allele frequencies were recorded as 0.884 for
type-I and 0.116 for type-2 based on our analysis of over
400 individuals including retinoblastoma patients in the UK
as described previously (Cowell et al., 1986a). This value is
not significantly different from that reported by Harris et al.
(1974). The lod score of 2.61 is in itself almost sufficient for
that required to establish linkage. No recombinants in 45
meioses have been observed in any other published reports
(Sparkes et al., 1983, Connolly et al., 1983; Mukai et al.,
1984; Halloran et al., 1985) giving a cumulative lod score of
13.69 (Table II)
Table I Maximum lod scores from
individual families (see Figure 1) for











The location of the ESD gene and the gene predisposing to
Rb to the same chromosome band suggests the possibility of
antenatal diagnosis of Rb using the electrophoretic
variants of ESD. Although the two loci are located within
the same half of band 13ql4 (Cowell et al., 1986b) this might
represent a large recombination distance. It is difficult to
assess the true distance between these two loci because of the
relatively low frequency of the type-2 ESD allele in Western
populations. The frequency of ESD heterozygotes is much
higher in the Japanese population at 0.46 (Horai &
Mutsunaga, 1984), so that the possibility of antenatal
diagnosis in that population should generally be possible.
Despite the low frequency of the 2-allele in the USA,
Sparkes et al. (1983) were able to demonstrate close linkage
using three large pedigrees. From their data alone no
recombination was observed from 12 phase-known meioses
with a lod score of 3.5. Connolly et al. (1983) reported a
single large family showing unusually low penetrance of the
Rb gene (71%). Unaffected family members transmitting the
gene were clearly identifiable. Assuming these individuals to
be gene carriers, cosegregation of the disease with the ESD
marker was seen in all meioses. Additional reports from
Mukai et al. (1984) and Halloran et al. (1985) also failed to
Table II Summed lod scores from the 6 informative families presented in this study
compared with the 6 families reported previously
Recombinationfraction
Penetrance Study 0.00 0.05 0.01 0.02 0.03 0.04
0.9 this study 2.61 2.31 2.01 1.41 0.85 0.30
0.9 previous reports 11.08 10.06 8.99 6.68 4.20 1.73
Total 13.69 12.37 11.00 8.09 5.05 2.03RETINOBLASTOMA-ESTERASE-D LINKAGE 663
demonstrate recombination between the ESD and Rb loci in
two additional families. The cumulative lod score from all of
these reports, including ours, is 13.69.
For accurate counselling of parents following antenatal
screening it is important to obtain a reliable estimate of the
linkage distance between ESD and the Rb locus. From the
available data we estimate that the true recombination
fraction is no greater than 6% at the 95% confidence limits,
and no greater than 10% at the 99% confidence limits.
Our series of families represents the largest group reported
to date. In addition to the low frequency of the rarer allele,
we have found that the small size of the families in the UK
make risk assessment more difficult. Undoubtedly genetic
counselling has had a major influence in these decisions.
Before the 1960s, when there was little counselling, families
tended to be larger, with more affected members.
Another problem encountered in our series was that in
only 3/7 cases did the Rb phenotype segregate with the rare
allele; the predictive value of this polymorphism cannot be
used in subsequent generations in the other 4 families. On
the other hand several families exist where phase has been
established and one of the affected children is heterozygous
as a result of the 2-allele being introduced by the unaffected
parent. In one family the affected child had the 2-2
phenotype which will again be uninformative in future
generations.
So far we have been able to track the inheritance of the
Rb locus in seven families of whom a number are being
counselled for prenatal diagnosis. We have also demonstrated
that the ESD phenotypes can be easily demonstrated in
fetal blood samples and in chorionic villus samples, thus
permitting antenatal diagnosis during the first trimester
(Ward et al., 1983; Rodeck et al., 1983). Although this
enzyme polymorphism will be invaluable for the families
reported here, because of the low frequency of the 2-allele in
the UK will restrict widespread use. The recent cloning of
the ESD gene (Squire et al., 1986; Lee & Lee, 1986) may
allow antenatal diagnosis in other families since the
inheritance can be followed using restriction fragment length
polymorphisms (see Cowell, 1985). The only informative
polymorphism identified to date shows a heterozygosity of
32% (Squire et al., 1986) which should prove more generally
useful than the ESD protein polymorphism. Several other
probes have also been tested for utility in antenatal diagnosis
of Rb; alone none of them were shown to be more closely
linked than the ESD gene (Craft personal communication).
Using flanking markers Cavenee et al. (1986) achieved
moderate success in prenatal prediction of Rb in three
families.
No recombinants in 45 meioses have been demonstrated
between the ESD and Rb loci (including the data from
Connolly et al., 1983) suggests close proximity of the ESD
and the Rb locus. Recently a candidate for the Rb gene has
been isolated (Friend et al., 1986). Even with the availability
of the Rb gene, however, antenatal diagnosis may still
require a combination of closely linked probes since some
families will be informative for only one probe. This
principle has been demonstrated with haemophilia A where,
despite the isolation of the factor VIII gene, the use of
flanking probes is essential for effective widespread antenatal
diagonsis (M.E. Pembrey, personal communication).
The ESD electrophoretic polymorphism is still the easiest
and most reliable of all of the available tests with results
available within 12-16 hours of the sample being taken. It is
expected that, with the eventual characterisation of the Rb
locus, specific genetic changes leading to the predisposition
will be identified in a manner similar to that already
demonstrated for thalassaemia (e.g. Old et al., 1986).
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